|
BRCA1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.839600E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.212300E-02 |
| Normal-vs-Stage2 |
2.201800E-01 |
| Normal-vs-Stage3 |
2.378300E-02 |
| Normal-vs-Stage4 |
1.240420E-01 |
| Stage1-vs-Stage2 |
2.366000E-01 |
| Stage1-vs-Stage3 |
5.388800E-01 |
| Stage1-vs-Stage4 |
5.293200E-01 |
| Stage2-vs-Stage3 |
1.681580E-01 |
| Stage2-vs-Stage4 |
6.763800E-01 |
| Stage3-vs-Stage4 |
3.902200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.658400E-02 |
| Normal-vs-AfricanAmerican |
5.041200E-01 |
| Normal-vs-Asian |
3.207600E-02 |
| Caucasian-vs-AfricanAmerican |
1.693570E-01 |
| Caucasian-vs-Asian |
9.906000E-01 |
| AfricanAmerican-vs-Asian |
1.847560E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.308400E-02 |
| Normal-vs-Female |
3.015800E-02 |
| Male-vs-Female |
2.824200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.687700E-02 |
| Normal-vs-Age(41-60Yrs) |
2.754100E-02 |
| Normal-vs-Age(61-80Yrs) |
1.009830E-01 |
| Normal-vs-Age(81-100Yrs) |
1.055930E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.129600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.211000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.033430E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.815800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.119200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.800400E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.462600E-03 |
| Classical-VS-Follicular |
2.649600E-04 |
| Classical-VS-Other |
4.782800E-01 |
| Classical-VS-Normal |
2.344300E-02 |
| Tall-VS-Follicular |
2.02319999975664E-07 |
| Tall-VS-Other |
2.061200E-01 |
| Tall-VS-Normal |
5.019000E-03 |
| Follicular-VS-Other |
5.337800E-01 |
| Follicular-VS-Normal |
4.006200E-01 |
| Other-VS-Normal |
2.258000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.921700E-02 |
| Normal-vs-N1 |
7.761900E-02 |
| N0-vs-N1 |
8.428400E-01 |
|
|
